Protein Detection Is Fastest Growing Segment Fueling The Growth Of Western Blotting Market
The global Western Blotting Market is estimated to be valued at US$ 759.5 Mn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Western blotting is a commonly used analytical technique used to detect
specific proteins in a given sample of cell lysate or tissue extract. It
identifies proteins by their molecular weights and provides information on
protein expression levels, modifications, and interactions.
Market key trends:
The protein detection segment dominated the market in 2019 and is expected to
maintain its dominance over the forecast period. This is due to increasing use
of western blotting for research purposes of proteomics and biomarker
discovery. It serves as an important tool for protein detection in various
samples like serum, plasma, cell extracts and tissues. As the detection
accuracy of western blotting is very high, it remains indispensable technique
in life science research.
Segment Analysis
Western Blotting market is segmented into instruments, consumables and
software. The consumables segment dominated the market in 2022 and is expected
to continue its dominance over the forecast period. This is attributed to the
recurring purchase of consumables such as antibodies, reagents and kits
required for each western blotting experiment performed.
Key Takeaways
The Global
Western Blotting Market Size is expected to witness high growth,
exhibiting a CAGR of 6.8% over the
forecast period, due to increasing research activities in proteomics.
Regional analysis
North America dominated the global Western Blotting market in 2022 and is
expected to continue its dominance over the forecast period. This is attributed
to the presence of major players and availability of advanced research
infrastructure in the region.
Key players analysis
Key players operating in the Western Blotting market are Thermo Fisher
Scientific, Inc., GE HealthCare, F. Hoffmann-La Roche Ltd, Lumigen, Inc., Merck
KGaA, Bio-Rad Laboratories, Inc., LI-COR, Inc., Bio-Techne, SBH Sciences,
Advansta Inc., Azure Biosystems Inc., HiMedia Laboratories., Elabscience
Biotechnology Inc., GenScript, Cell Signaling Technology, Inc., ICL, Inc.,
Takara Bio Inc., Leinco Technologies.
Read
More: https://www.ukwebwire.com/western-blotting-market-size-share-and-growth-forecast-2023-2023/
Comments
Post a Comment